1-5 of 5
Dieter Kabelitz
Close
Sort by
Journal Articles

Delta One T cells recognize AML via DNAM-1

Dieter Kabelitz
Journal: Blood
Blood (2024) 143 (15): 1434–1436.
https://doi.org/10.1182/blood.2024024120
Published: 2024
Journal Articles

Hematopoietic stem cell involvement in BCR-ABL1– positive ALL as a potential mechanism of resistance to blinatumomab therapy

Brief Report
Inga Nagel, Marius Bartels, Johannes Duell, Hans-Heinrich Oberg, Sandra Ussat, Henrike Bruckmueller, Oliver Ottmann, Heike Pfeifer, Heiko Trautmann, Nicola Gökbuget, Almuth Caliebe, Dieter Kabelitz, Michael Kneba, Heinz-August Horst, Dieter Hoelzer, Max S. Topp, Ingolf Cascorbi, Reiner Siebert, Monika Brüggemann
Journal: Blood
Blood (2017) 130 (18): 2027–2031.
https://doi.org/10.1182/blood-2017-05-782888
Published: 2017
Includes: Supplemental data
Journal Articles

CD277 takes the lead in human γδ T-cell activation

Dieter Kabelitz
Journal: Blood
Blood (2012) 120 (11): 2159–2161.
https://doi.org/10.1182/blood-2012-07-442731
Published: 2012
Journal Articles

Hard time for anergic cytotoxic T cells

Dieter Kabelitz
Journal: Blood
Blood (2004) 103 (1): 3–4.
https://doi.org/10.1182/blood-2003-10-3506
Published: 2004
Journal Articles

Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies

Sandra Siegel, Andreas Wagner, Dieter Kabelitz, Matthias Marget, Joseph Coggin, Jr, Adel Barsoum, James Rohrer, Norbert Schmitz, Matthias Zeis
Journal: Blood
Blood (2003) 102 (13): 4416–4423.
https://doi.org/10.1182/blood-2003-01-0198
Published: 2003